Evidence map›Paper›PMID 28100544›Full record

Trial reportHeart (British Cardiac Society)2017

Oscillatory whole-body vibration improves exercise capacity and physical performance in pulmonary arterial hypertension: a randomised clinical study.

Felix Gerhardt, Daniel Dumitrescu, Carina Gärtner, Ralf Beccard, Thomas Viethen, Tilmann Kramer, Stephan Baldus, Martin Hellmich, Eckhard Schönau, Stephan Rosenkranz

2 registry-linked trialsOpen access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Heart (British Cardiac Society), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 18 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 6 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01763112 naunknown statusnot on this map

Influence of Training With Whole Body Vibration Device (Galileo) on Quality of Life (QoL), Exercise Capacity, as Well as on the Effects of Muscle Power and Muscle Function in Patients With Pulmonal Arterial Hypertension (PAH). (GALILEO PAH)

TypeinterventionalSponsorKlinikum der Universität KölnRan2013 to 2015Enrolled20ConditionsPulmonary Artery HypertensionArmsExercise Group Galileo PAH
NCT04162054 unknown statusnot on this mapstarted 2020, after this paper: background citation

Observation of Acute Cardiopulmonary Effects in Healthy Individuals Performing Cardiopulmonary Exercise Test (CPX) During Whole Body Vibration (WBV)

TypeobservationalSponsorKlinikum der Universität KölnRan2020 to 2020Enrolled20ConditionsAcute Cardiopulmonary EffectsArmsObservational study to evaluate acute cardiopulmonary effects of whole body vibration (WBV) on healthy individuals analysed in non-invasive cardiopulmonary exercise test (CPX).
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 6 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Exercise-based rehabilitation programmes for pulmonary hypertension.The Cochrane database of systematic reviews · 2023
    Pooled it
  5. The effect of whole body vibration on health-related quality of life in patients with chronic conditions: a systematic review.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2019
    Pooled it
  6. Pooled it
  7. Trial
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. The Use of Vibration Training in Men after Myocardial Infarction.International journal of environmental research and public health · 2022
    Article
  14. Article
  15. Review
  16. Bone in heart failure.Journal of cachexia, sarcopenia and muscle · 2020
    Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Felix GerhardtKlinik III für Innere Medizin, Herzzentrum der Universität zu Köln, Cologne, Germany.
Daniel DumitrescuKlinik III für Innere Medizin, Herzzentrum der Universität zu Köln, Cologne, Germany.
Carina GärtnerKlinik III für Innere Medizin, Herzzentrum der Universität zu Köln, Cologne, Germany.
Ralf BeccardKlinik und Poliklinik für Allgemeine Kinderheilkunde, Universität zu Köln, Cologne, Germany.
Thomas ViethenKlinik III für Innere Medizin, Herzzentrum der Universität zu Köln, Cologne, Germany.
Tilmann KramerKlinik III für Innere Medizin, Herzzentrum der Universität zu Köln, Cologne, Germany.
Stephan BaldusKlinik III für Innere Medizin, Herzzentrum der Universität zu Köln, Cologne, Germany.
Martin HellmichInstitut für Medizinische Statistik, Informatik und Epidemiologie, Universität zu Köln, Cologne, Germany.
Eckhard SchönauKlinik und Poliklinik für Allgemeine Kinderheilkunde, Universität zu Köln, Cologne, Germany.
Stephan RosenkranzKlinik III für Innere Medizin, Herzzentrum der Universität zu Köln, Cologne, Germany.
University of Cologne · DEZentrum für Kinderheilkunde · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIn patients with pulmonary arterial hypertension (PAH), supportive therapies may be beneficial in addition to targeted medical treatment. Here, we evaluated the effectiveness and safety of oscillatory whole-body vibration (WBV) in patients on stable PAH therapy.

methodsTwenty-two patients with PAH (mean PAP≥25 mm Hg and pulmonary arterial wedge pressure (PAWP)≤15 mm Hg) who were in world health organization (WHO)-Functional Class II or III and on stable PAH therapy for≥3 months, were randomised to receive WBV (16 sessions of 1-hour duration within 4 weeks) or to a control group, that subsequently received WBV. Follow-up measures included the 6-min walking distance (6MWD), cardiopulmonary exercise testing (CPET), echocardiography, muscle-power, and health-related quality of life (HRQoL; SF-36 and LPH questionnaires).

resultsWhen compared to the control group, patients receiving WBV exhibited a significant improvement in the primary endpoint, the 6MWD (+35.4±10.9 vs -4.4±7.6 m), resulting in a net benefit of 39.7±7.8 m (p=0.004). WBV was also associated with substantial improvements in CPET variables, muscle power, and HRQoL. The combined analysis of all patients (n=22) indicated significant net improvements versus baseline in the 6MWD (+38.6 m), peakVO2 (+65.7 mL/min), anaerobic threshold (+40.9 mL VO

conclusionsWBV substantially improves exercise capacity, physical performance, and HRQoL in patients with PAH who are on stable targeted therapy. This methodology may be utilised in structured training programmes, and may be feasible for continuous long-term physical exercise in these patients. TRIAL REGISTRATION NUMBER: NCT01763112; Results.

Indexed as

Exercise TolerancePulmonary Wedge PressureAdultAgedAged, 80 and overCardiorespiratory FitnessEchocardiographyFemaleGermanyHealth StatusHumansHypertension, PulmonaryMaleMiddle AgedMuscle StrengthOscillometry

Identifiers

PMID28100544
PMCPMC5529961
OpenAlexW2572088783

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.